CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less radiation mean fewer side effects for throat cancer patients?
Disease control Not yet recruitingThis study is testing whether a lower dose of radiation to healthy lymph nodes in the neck can reduce treatment side effects while still effectively curing HPV-related throat cancer. It will enroll 100 adults with early-stage cancer who have not had prior treatment. The goal is t…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for patients who Can't take standard chemo
Disease control Not yet recruitingThis study aims to find the best treatment for people with advanced head and neck cancer who cannot safely take the standard chemotherapy drug, cisplatin. It will compare two different drug combinations, each given alongside targeted radiation therapy, in about 454 patients. The …
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC